hip implant lawsuit
Smith and Nephew Inc was becoming accused of violating Food and Drug Administration regulations when generating its hip replacement devices.
An FDA letter addressed to chairman John G.S. Buchanan dated Dec. 21 outlined violations at a manufacturing plant in Tuttlingen, Germany.
It was signed by the FDA’s Steven D. Silverman, director, Workplace of Compliance, Center for Devices and Radiological Wellness. The letter was posted to FDA’s web site on Tuesday.
It indicates that correspondence in between the company and the FDA has been on-going for some time. It outlines 5 locations of corrective action.
Find out if you are eligible for a hip implant lawsuit
Related Posts
Tags
Share This
Recent Comments